US2005272092A1PendingUtilityA1
Novel gene having reverse transcriptas motif
Est. expiryJan 8, 2018(expired)· nominal 20-yr term from priority
C12N 9/1276C12Y 207/07049
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention aims to provide a novel gene having a reverse transcriptase motif. The invention isolates a novel gene having a reverse transcriptase motif, and gives its complete base sequence determined. The invention also provides a protein encoded by the gene, and an antibody against the protein. The use of them is useful in developing a method for detecting telomerase activity, a method for detecting a cancer cell, a telomerase activity inhibitor, and a method for screening a telomerase activity inhibitor.
Claims
exact text as granted — not AI-modified1 - 15 . (canceled)
16 . An antibody against a protein selected from the group consisting of:
a protein comprising the amino acid sequence of SEQ ID NO: 2; a protein comprising an amino acid sequence containing one amino acid substitution, deletion or addition as compared to SEQ ID NO: 2, wherein the protein has reverse transcriptase activity; a protein comprising the amino acid sequence of SEQ ID NO: 10; a protein comprising an amino acid sequence containing one amino acid substitution, deletion or addition as compared to SEQ ID NO: 10, wherein the protein has reverse transcriptase activity; a protein comprising the amino acid sequence of SEQ ID NO: 12; and a protein comprising an amino acid sequence containing one amino acid substitution, deletion or addition as compared to SEQ ID NO: 12, wherein the protein has reverse transcriptase activity.
17 . A cancer diagnostic agent comprising the antibody of claim 16.Join the waitlist — get patent alerts
Track US2005272092A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.